The key mechanisms of action in the low back pain pipeline drugs market are Prostaglandin G/H Synthase 2 Inhibitor, Prostaglandin G/H Synthase 1 Inhibitor, Cannabinoid Receptor 1 Agonist, Cannabinoid Receptor 2 Agonist, and Mu Type Opioid Receptor Agonist among others. Prostaglandin G/H Synthase 2 Inhibitor led the market in 2022. https://www.globaldata.com/store/report/low-back-pain-drugs-in-development-analysis/